Literature DB >> 16003713

Is there an overlap between Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy/dysplasia?

Andrés Ricardo Pérez Riera1, Charles Antzelevitch, Edgardo Schapacknik, Sergio Dubner, Celso Ferreira.   

Abstract

The Brugada syndrome is a congenital syndrome displaying an autosomal dominant mode of transmission in patients with a structurally normal heart. The disease has been linked to mutations in SCN5A , a gene located on the short arm of chromosome 3 (p21-24) that encodes for the alpha subunit of the sodium channel. The syndrome is characterized by a dynamic ST-segment elevation (accentuated J wave) in leads V 1 to V 3 of the ECG followed by negative T wave. Right bundle-branch block of varying degrees is observed in some patients. The syndrome is associated with syncope and a relatively high incidence of sudden cardiac death secondary to the development of polymorphic ventricular tachycardia that may degenerate into ventricular fibrillation. An acquired form of the Brugada syndrome is also recognized, caused by a wide variety of drugs and conditions that alter the balance of currents active during the early phases of the action potential. Among patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia, there is a subpopulation with a clinical and electrocardiographic pattern similar to that of the Brugada syndrome. These cases of arrhythmogenic right ventricular cardiomyopathy/dysplasia are thought to represent an early or concealed form of the disease. This review examines the overlap between these 2 syndromes.

Entities:  

Mesh:

Year:  2005        PMID: 16003713      PMCID: PMC1479891          DOI: 10.1016/j.jelectrocard.2005.03.009

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  37 in total

1.  Localization of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23.

Authors:  F Ahmad; D Li; A Karibe; O Gonzalez; T Tapscott; R Hill; D Weilbaecher; P Blackie; M Furey; M Gardner; L L Bachinski; R Roberts
Journal:  Circulation       Date:  1998 Dec 22-29       Impact factor: 29.690

2.  Dedifferentiation of atrial cardiomyocytes as a result of chronic atrial fibrillation.

Authors:  J Ausma; M Wijffels; G van Eys; M Koide; F Ramaekers; M Allessie; M Borgers
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 3.  Idiopathic ventricular fibrillation of the Brugada type: an atypical form of arrhythmogenic right ventricular cardiomyopathy?

Authors:  T Ohe
Journal:  Intern Med       Date:  1996-08       Impact factor: 1.271

4.  Familial cardiomyopathy associated with right bundle branch block, ST segment elevation and sudden death.

Authors:  G Fontaine
Journal:  J Am Coll Cardiol       Date:  1996-08       Impact factor: 24.094

Review 5.  [Malignant ventricular arrhythmias in patients with a right bundle-branch block and persistent ST segment elevation in V1-V3: a probable arrhythmogenic cardiomyopathy of the right ventricle].

Authors:  F Naccarella
Journal:  G Ital Cardiol       Date:  1993-12

6.  Let us do not get confused, please!...

Authors:  P Brugada; J Brugada
Journal:  G Ital Cardiol       Date:  1994-06

7.  Genetic basis and molecular mechanism for idiopathic ventricular fibrillation.

Authors:  Q Chen; G E Kirsch; D Zhang; R Brugada; J Brugada; P Brugada; D Potenza; A Moya; M Borggrefe; G Breithardt; R Ortiz-Lopez; Z Wang; C Antzelevitch; R E O'Brien; E Schulze-Bahr; M T Keating; J A Towbin; Q Wang
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

8.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.

Authors:  W J McKenna; G Thiene; A Nava; F Fontaliran; C Blomstrom-Lundqvist; G Fontaine; F Camerini
Journal:  Br Heart J       Date:  1994-03

9.  SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia.

Authors:  William P McNair; Lisa Ku; Matthew R G Taylor; Pam R Fain; Dmi Dao; Eugene Wolfel; Luisa Mestroni
Journal:  Circulation       Date:  2004-10-04       Impact factor: 29.690

10.  Effect of calcium channel block on the wall motion abnormality of the idiopathic long QT syndrome.

Authors:  G M De Ferrari; F Nador; G Beria; S Sala; A Lotto; P J Schwartz
Journal:  Circulation       Date:  1994-05       Impact factor: 29.690

View more
  6 in total

Review 1.  Brugada syndrome.

Authors:  Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2006-10       Impact factor: 1.976

2.  Epsilon-like electrocardiographic pattern in a patient with Brugada syndrome.

Authors:  Ozcan Ozeke; Umut Y Cavus; Ilyas Atar; Bulent Ozin; Erdogan Ilkay
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-07       Impact factor: 1.468

3.  Diagnostic dilemmas: overlapping features of brugada syndrome and arrhythmogenic right ventricular cardiomyopathy.

Authors:  Mark G Hoogendijk
Journal:  Front Physiol       Date:  2012-05-23       Impact factor: 4.566

4.  Brugada ECG pattern: a physiopathological prospective study based on clinical, electrophysiological, angiographic, and genetic findings.

Authors:  Guillaume Duthoit; Véronique Fressart; Françoise Hidden-Lucet; Françoise Simon; Darouna Kattygnarath; Philippe Charron; Caroline Himbert; Philip Aouate; Pascale Guicheney; Yves Lecarpentier; Robert Frank; Jean-Louis Hébert
Journal:  Front Physiol       Date:  2012-12-27       Impact factor: 4.566

Review 5.  Cell models of arrhythmogenic cardiomyopathy: advances and opportunities.

Authors:  Elena Sommariva; Ilaria Stadiotti; Gianluca L Perrucci; Claudio Tondo; Giulio Pompilio
Journal:  Dis Model Mech       Date:  2017-07-01       Impact factor: 5.758

Review 6.  Recent Non-Invasive Parameters to Identify Subjects at High Risk of Sudden Cardiac Death.

Authors:  Maria Delia Corbo; Enrica Vitale; Maurizio Pesolo; Grazia Casavecchia; Matteo Gravina; Pierluigi Pellegrino; Natale Daniele Brunetti; Massimo Iacoviello
Journal:  J Clin Med       Date:  2022-03-10       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.